B. Cutuli, C. Charles, F. Bancheri, Y. Caron, D. Coeffic, P. Colin, P.H. Dorangeon, S. Ferrand, N. Gavillon, C.G. Hemery, N. Jovenin, L. Krebs, A.R. Majidi, F. Mallet, W. Mina, K. Prulhiere-Corviole, P. Terrosi, A. Theillier, I. Veron-Leclercq, G. Yazbek
{"title":"基因组特征适应症及其对辅助化疗内分泌疗法 (CET) 决策影响的实际分析:来自法国 LISE 队列(n = 301)的经验","authors":"B. Cutuli, C. Charles, F. Bancheri, Y. Caron, D. Coeffic, P. Colin, P.H. Dorangeon, S. Ferrand, N. Gavillon, C.G. Hemery, N. Jovenin, L. Krebs, A.R. Majidi, F. Mallet, W. Mina, K. Prulhiere-Corviole, P. Terrosi, A. Theillier, I. Veron-Leclercq, G. Yazbek","doi":"10.1016/j.ejca.2024.113867","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"76 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Real-world analysis of genomic signature indications and impact on adjuvant chemoendocrine therapy (CET) decisions: experience from the French LISE cohort (n = 301)\",\"authors\":\"B. Cutuli, C. Charles, F. Bancheri, Y. Caron, D. Coeffic, P. Colin, P.H. Dorangeon, S. Ferrand, N. Gavillon, C.G. Hemery, N. Jovenin, L. Krebs, A.R. Majidi, F. Mallet, W. Mina, K. Prulhiere-Corviole, P. Terrosi, A. Theillier, I. Veron-Leclercq, G. Yazbek\",\"doi\":\"10.1016/j.ejca.2024.113867\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":505596,\"journal\":{\"name\":\"European Journal of Cancer\",\"volume\":\"76 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ejca.2024.113867\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ejca.2024.113867","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Real-world analysis of genomic signature indications and impact on adjuvant chemoendocrine therapy (CET) decisions: experience from the French LISE cohort (n = 301)